Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $150.00 ($2.3M) on 2012-09-05, disclosed to the SEC on 2012-09-06.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.00 | 1,286 | $193K | 8.6% |
| 2 | $150.00 | 13,714 | $2.1M | 91.4% |
| Total | $150.00 avg | 15,000 | $2.3M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |